DNA - 3 Stocks Cathie Wood Is Buying That Should Be on Your List Too
Back-to-school supplies and updates to your autumn wardrobe are popular things on people's shopping lists these days. Noted investor and Ark Invest CEO Cathie Wood, meanwhile, has been scooping up shares of growth stocks for her various ARK exchange-traded funds (ETFs).
While I can't say that I agree with all of Wood's stock purchases over the past few months, there are some stocks that her funds have snatched up that would seem to fit well in other growth investors' portfolios. They include Ginkgo Bioworks (NYSE: DNA) , Monday.com (NASDAQ: MNDY) , and Trimble (NASDAQ: TRMB) . Let's find out a bit more about these three Cathie Wood stocks that are worth more consideration.
A leader in the field of synthetic biology, or synbio, Ginkgo Bioworks specializes in providing its customers with improved molecules. Essentially, the company acts like an architect. Customers -- from a variety of industries, including food, pharmaceuticals, and cosmetics -- inform Ginkgo of their needs, and Ginkgo designs the blueprints for new and improved microbes. Often, Ginkgo will earn royalties or equity interests as a result of these partnerships, providing the company with good foresight into future cash flows.
For further details see:
3 Stocks Cathie Wood Is Buying That Should Be on Your List Too